These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80years old): Extremely safe and effective. Kreinbrink P; Blumenfeld P; Tolekidis G; Sen N; Sher D; Marwaha G J Geriatr Oncol; 2017 Sep; 8(5):351-355. PubMed ID: 28739159 [TBL] [Abstract][Full Text] [Related]
11. Five- Versus Ten-Fraction Regimens of Stereotactic Body Radiation Therapy for Primary and Metastatic NSCLC. Steber CR; Hughes RT; Soike MH; Jacobson T; Helis CA; Farris JC; Farris MK Clin Lung Cancer; 2021 Jan; 22(1):e122-e131. PubMed ID: 33046359 [TBL] [Abstract][Full Text] [Related]
12. Prior Treatment for Non-small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy: A Retrospective Multivariate and Matched Pair Analysis. Farrugia MK; Jun Ma S; Hennon MW; Nwogu CE; Dexter EU; Picone AL; Demmy TL; Gomez-Suescun JA; Fung-Kee-Fung S; Yendamuri SS; Singh AK Am J Clin Oncol; 2021 Jan; 44(1):18-23. PubMed ID: 33264123 [TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry. Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848 [TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates. Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274 [TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer. Yan SX; Qureshi MM; Dyer M; Truong MT; Mak KS Lung Cancer; 2019 May; 131():147-153. PubMed ID: 31027693 [TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiation Therapy With a High Maximum Dose Improves Local Control, Cancer-Specific Death, and Overall Survival in Peripheral Early-Stage Non-Small Cell Lung Cancer. Tateishi Y; Takeda A; Horita N; Tsurugai Y; Eriguchi T; Kibe Y; Sanuki N; Kaneko T Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):143-151. PubMed ID: 33891980 [TBL] [Abstract][Full Text] [Related]
17. Stereotactic Body Radiation Therapy for Biopsy-Proven Primary Non-Small-Cell Lung Cancer: Experience of Patients With Inoperable Cancer at a Single Brazilian Institution. Abreu CECV; Moraes FY; Miranda FA; Siqueira GSM; Gadia R; Haddad CK; Carvalho HA J Glob Oncol; 2018 Jul; 4():1-8. PubMed ID: 30085881 [TBL] [Abstract][Full Text] [Related]
18. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma. Kann BH; Verma V; Stahl JM; Ross R; Dosoretz AP; Shafman TD; Gross CP; Park HS; Yu JB; Decker RH Radiother Oncol; 2019 May; 134():44-49. PubMed ID: 31005223 [TBL] [Abstract][Full Text] [Related]
19. Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer. Meng MB; Wang HH; Zaorsky NG; Sun BS; Zhu L; Song YC; Li FT; Dong Y; Wang JS; Chen HM; Yu XY; Yuan ZY Cancer Sci; 2019 Nov; 110(11):3553-3564. PubMed ID: 31464032 [TBL] [Abstract][Full Text] [Related]
20. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer. Parks J; Kloecker G; Woo S; Dunlap NE Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]